Skip to main content
NCBI home page
Life logoLink to Life
. 2021 Mar 22;11(3):260. doi: 10.3390/life11030260

Clinical Characteristics, Differential Diagnosis and Genetic Analysis of Concentric Retinitis Pigmentosa

Mei Nakahara 1, Akio Oishi 1,2,*, Manabu Miyata 1, Hanako Ohashi Ikeda 1, Tomoko Hasegawa 1, Shogo Numa 1, Yuki Otsuka 1, Maho Oishi 1, Fumihiko Matsuda 3, Akitaka Tsujikawa 1
Editor: Ayumi Ouchi
PMCID: PMC8004166  PMID: 33809962

Abstract

Concentric retinitis pigmentosa (RP), in which retinal degeneration is limited in the periphery, is rare and little information exists to date on the subject. Herein, we describe the clinical and genetic characteristics of this atypical form of RP. We retrospectively reviewed our database and identified 14 patients with concentric RP. Additionally, 14 patients with age-matched typical RP were also included. Patients with concentric RP had better visual acuity (logarithm of minimum angle of resolution −0.04 vs. 0.32, p = 0.047) and preserved ellipsoid zones (7630 µm vs. 2646 µm, p < 0.001) compared to typical RP. The electroretinogram showed subnormal but recordable responses in patients with concentric RP. Genetic testing was done in nine patients with concentric RP and revealed causative mutations in the EYS gene in one patient and the RP9 gene in one patient. Two patients had myotonic dystrophy and the diagnosis was revised as myotonic dystrophy-associated retinopathy. Concentric RP is a rare, atypical form of RP with better visual function. There is some overlap in the causative genes in concentric and typical RP. Myotonic dystrophy-associated retinopathy is an important differential diagnosis.

Keywords: retinal dystrophy, retinitis pigmentosa, concentric retinitis pigmentosa, myotonic dystrophy, fundus autofluorescence

1. Introduction

Inherited retinal dystrophy (IRD) includes a heterogenous group of diseases characterized by retinal cell death/impairment due to genetic causes. The most common form is retinitis pigmentosa (RP), which is a major cause of visual impairment in developed countries [1]. The classic triad of RP is bony spicule pigmentation, vessel attenuation and waxy pallor optic disc. The retinal degeneration generally starts with the mid-peripheral retina, inducing ring-shaped or concentric visual field loss, and progresses toward the macular and the periphery.

Ultra-wide-field scanning laser ophthalmoscopy is one of recent developments of imaging techniques in ophthalmology. It enables the observation of the peripheral retina with a single image [2]. Fundus autofluorescence (FAF) imaging is another imaging technique which visualizes retinal intrinsic fluorescent material. The degenerated retina and pigment epithelium generally show decreased FAF, and these are clearly depicted with the imaging [3]. A combination of these techniques, ultra-wide-field FAF imaging, is useful for monitoring patients with RP and provides otherwise inaccessible information [4].

Since we started routine examinations with peripheral FAF imaging, we noticed some cases with retinal degeneration limited to the peripheral retina. The clinical appearance reminded us of concentric RP, which was first described in a paper investigating visual field progression [5], and named later by Jacobson’s group [6]. They reported clinicopathologic pathologic finding of the disease; however, little was added thereafter. Autosomal dominant vitreoretinochoroidopathy (ADVIRC) is also characterized by a peripheral and circumferential retinal band of pigmentary alterations, and often accompanies microcornea [7]. Mutations of BEST1 were identified as a cause of the disease [8]. In the present study, we describe multimodal imaging phenotypes and the genetic analysis of concentric RP in comparison with typical RP. In addition, another differential diagnosis, myotonic dystrophy-associated retinopathy, is discussed.

2. Materials and Methods

This retrospective study was approved by the ethics committee of the Kyoto University Graduate School of Medicine (Kyoto, Japan, study ID: R2198). The research followed the tenets of the Declaration of Helsinki. Some of the patients also participated in genetic testing study, which was approved by the same ethics committee (G0746-8), and the participants provided written informed consent.

We reviewed the in-house database of patients who visited the retinal dystrophy clinic of Kyoto University Hospital between January 2012 and December 2019. To extract the specific case series of concentric RP, we defined following criteria: (1) bilaterally symmetrical peripheral retinal degeneration with or without bony spicule pigmentation; (2) the four-disc-diameter area centering the fovea is spared on FAF image (Figure 1); (3) absence of other acquired retinal diseases, particularly age-related macular degeneration; (4) no history of intraocular surgery other than cataracts. The age of onset and initial symptoms were recorded from clinical interviews.

Figure 1.

Figure 1

Open in a new tab

Wide-field fundus autofluorescent images of concentric retinitis pigmentosa (RP) (A) and typical RP (B). In the present study, concentric RP was defined as the preservation of at least a four-disc-diameter area from the fovea. As shown in panel B, this criterion excluded virtually all the typical RP cases.

To highlight the distinct clinical characteristics of the patients, we recruited age-matched patients with typical RP. A patient with the closest birthday was selected for each patient with concentric RP. We investigated visual acuity, measured with the Landolt chart and converted to the logarithm of minimum angle of resolution (LogMAR), a mean deviation and a central threshold of the Humphrey visual field analyzer 10-2 program. Horizontal and vertical scans through the fovea were obtained with spectral-domain optical coherence tomography (Spectralis, Heidelberg Engineering, Heidelberg, Germany). The central retinal thickness was measured from inner surface of the internal limiting membrane to the inner surface of the retinal pigment epithelium, and the width of the ellipsoid zone was measured on the horizontal and vertical images and averaged for each patient. The measurements for the right eye were compared between concentric RP and typical RP using an unpaired t-test. Data are presented as mean ± standard deviation. The Snellen equivalent is presented for visual acuity for easier understanding. Goldmann kinetic visual field tests were reviewed when available.

Genetic testing was done as previously reported [9,10,11].

3. Results

There were 1776 patients with IRD including 673 with RP during the study period. We identified 15 patients from 14 families with concentric RP who met all the inclusion criteria, but 1 patient was excluded because the patient was accompanied with central serous chorioretinopathy at the initial presentation. Thus, we analyzed 14 cases from 13 families with concentric RP. As the prevalence indicates, the criteria successfully differentiated typical RP. Additionally, 14 age-matched patients from 14 families with typical RP were also included. Details of all the patients are shown in Table 1 and a representative case is shown in Figure 2.

Table 1.

Clinical characteristics of patients with concentric RP included in the study.

Sex Age Onset Age Symptom Visual Acuity Scotopic ERG Photopic ERG Detected Mutation Comorbidities
#1 * Woman 29 22 photopsia 1.2 normal normal none Renal dysfunction
#2 * Woman 36 28 blurred vision at evening 1.2 non recordable normal none
#3 Woman 41 diagnosed at 38 none 1.2 unavailable unavailable unavailable Interstitial pneumonia
#4 Woman 47 unclear unclear 0.8 reduced amplitude reduced amplitude none Myotonic dystrophy, Diabetes
#5 Woman 50 20s blurred vision and floaters 1.2 unavailable unavailable unavailable Myotonic dystrophy
#6 Man 64 58 blurred vision at evening 1.0 reduced amplitude reduced amplitude none Intervertebral disc hernia
#7 Man 66 unclear unclear 1.2 reduced amplitude reduced amplitude unavailable Angina pectoris
#8 Woman 69 diagnosed at 62 none 1.2 unavailable unavailable EYS (c.2528G>A: p.G843E, homozygous)
#9 Man 70 40s nyctalopia 1.5 reduced amplitude normal none
#10 Woman 71 diagnosed at 60 none 1.0 reduced amplitude reduced amplitude unavailable Thyroid gland cancer
#11 Woman 74 50s nyctalopia 1.2 reduced amplitude reduced amplitude none Diabetes
#12 Woman 75 58 stumbling (visual field restriction) 0.9 reduced amplitude reduced amplitude none
#13 Man 79 40s nyctalopia 0.9 reduced amplitude reduced amplitude none
#14 Man 87 diagnosed at 66 none 1.0 reduced amplitude reduced amplitude RP9 (c.509A>G: p.D170G) Diabetes, Coronary artery occlusion
Open in a new tab

* #1 and #2 are siblings; visual acuity and decimal visual acuity measured with Landolt C charts; ERG, electroretinogram.

Figure 2.

Figure 2

Open in a new tab

Wide-field fundus autofluorescent (A,B), pseudo-color (C,D), optical coherence tomography (OCT; (E,F)) and Goldmann kinetic perimetry (G,H) images of a representative case of concentric RP (Patient #3). OCT scan lines are shown in panels C and D. V/4e, I/4e and I/2e isopters are traced in panels G and H. Note the symmetric and well-demarcated peripheral retinal degeneration. The outer nuclear layer and ellipsoid zone were relatively well preserved despite focal thinning and impairment. Mild concentric constriction of the visual field was noted.

The mean age of the concentric RP patients was 61.3 ± 17.6 and five patient (26.3%) were men. Patients #1 and #2, who are siblings, reported that their father was diagnosed with some retinal dystrophy, but the details were unavailable. The other cases were sporadic. Two unrelated cases (Patients #4 and #5) had myotonic dystrophy as a comorbidity and were considered as myotonic dystrophy-associated retinopathy (Figure 3). None reported the use of chlorpromazine, thioridazine or hydroxychloroquine. None reported an episode of acute or subacute vision loss, indicating the absence of past uveitis or acute zonal occult outer retinopathy. The corneal diameter was measured in seven patients and showed normal values (>11 mm). None of the patients had a cystoid macular edema. Patient #13 developed a macular hole during the follow-up visit. Goldmann kinetic perimetry was done in seven patients and showed concentric visual field constriction corresponding to the peripheral degeneration.

Figure 3.

Figure 3

Open in a new tab

Wide-field fundus autofluorescent (A,B), pseudo-color (C,D) and optical coherence tomography (E,F) images of two cases of myotonic dystrophy-associated retinopathy (Patients #4 and #5).

Table 2 shows comparison of clinical characteristics of concentric RP and typical RP. As expected, patients with concentric RP had better visual acuity, central visual field, central threshold, photopic and scotopic electroretinogram (ERG) amplitude and a wider ellipsoid zone. The representative ERG is shown in Figure 4. The central threshold also looked larger, but there was no statistical significance. The central retinal thickness was not different between the two groups, partly due to the cases with cystoid macular edema and epiretinal membrane-induced retinal thickening being included in the typical RP group.

Table 2.

Comparison between concentric retinitis pigmentosa and typical retinitis pigmentosa.

Concentric RP (n = 14) Typical RP
(n = 14)		 p-Value Reference
In-House Normal Range
Age (years) 61.3 ± 17.6 61.4 ± 17.1 0.99
Sex (Man/Woman) 5/9 5/9 1.00
Visual acuity (logMAR) −0.04 ± 0.07 0.32 ± 0.60 0.047
HFA 10-2 MD (dB) −3.1 ± 3.0 −18.1 ± 11.8 <0.001
Central threshold (dB) 33.7 ± 2.1 27.8 ± 9.6 0.04
Dark adapted 0.01 ERG b-wave (µV) 28.9 ± 20.5 6.3 ± 11.9 0.002 81–128
Dark adapted 3.0 ERG a-wave (µV) 55.9 ± 34.6 15.0 ± 17.4 0.003 67–281
Dark adapted 3.0 ERG b-wave (µV) 102.1 ± 39.2 23.5 ± 23.3 <0.001 139–361
Light adapted 3.0 ERG b-wave (µV) 59.0 ± 23.8 12.1 ± 9.9 <0.001 83–259
Central retinal thickness (µm) 215.6 ± 42.0 218.8 ± 116.0 0.92
Ellipsoid zone width (µm) 7630 ± 1284 2646 ± 2488 <0.001
Open in a new tab

RP, retinitis pigmentosa; logMAR, logarithm of minimum angle of resolution; HFA, Humphrey visual field analyzer; MD, mean deviation; ERG, electroretinogram.

Figure 4.

Figure 4

Open in a new tab

Representative electroretinogram (ERG) waveforms of patients with concentric retinitis pigmentosa (Patient #9), age-matched retinitis pimentosa and a normal subject. The concentric retinitis pigmentosa patient still showed reduced but recordable ERG in his 60s.

Eight patients with concentric RP underwent direct sequencing of BEST1 and eight underwent exome sequencing (DNA sample was unavailable in five patients). The screening revealed a homozygous EYS mutation in one patient and a heterozygous RP9 mutation in another patient. The identified variants are shown in Table 1. Exome sequencing was done for 13 patients in the typical RP group, and revealed EYS (2 patients, c.4957dupA homozygous and c.4957dupA/c.8805C>A), RHO (1 patient, c.44A>G), CEP164 (1 patient, c.452G>A homozygous) and CNGA1 (1 patient, c.398delG/c.1196A>G) as causative genes.

4. Discussion

In the present paper, we describe the characteristics of patients with concentric RP who exhibited retinal degeneration only in the periphery. Two of the included patients were later diagnosed with myotonic dystrophy-associated retinopathy. Two patients showed causative mutations in RP-associated genes. The report provides representative figures for the long-unattended phenotype.

Patients with concentric RP showed some distinct features compared to typical RP. Firstly, as defined by the inclusion criteria, the four-disc-diameter retina was spared. This is very rare in typical RP, even in the early stages. The area is generally affected, even in another mild phenotype sectoral RP [12]. Although the age of onset was not specified in all cases, more than half of the cases were patients older than 60 years, indicating that the disease progresses slowly, or that the onset is late compared to typical RP. Corresponding to the spared retina, the ERG was recordable in all the examined patients, even those in their 60s. This is also uncommon in typical RP. Meanwhile, genetic testing revealed mutations of RP-associated genes in some patients. The result indicates that these patients, at least those with identified causative mutations in the RP gene, have an atypical mild phenotype of RP compared to sectoral RP [12,13]. The original report also discussed the presumed X factor that induced retinal degeneration from the periphery, but it has yet to be elucidated [6]. Investigating what makes peripheral degeneration occur and why these patients retain the mild phenotype might lead to identifying modifiable factors for the disease.

The involvement of the peripheral retina with macular sparing suggests ADVIRC as a differential diagnosis. The disease is characterized by a peripheral circumferential retinal band of pigmentary alterations [7]. Mutations of BEST1 were identified as a cause of the disease [8]. Indeed, the present cases showed similar pigmentary degeneration in the peripheral retina. However, none of the investigated patients had mutations in BEST1. Microcornea, which is common in ADVIRC, was not observed either. Vitreoretinal dystrophy, such as Stickler syndrome and Wagner syndrome, also affects the peripheral retina [14,15], but it is less likely, considering the lack of systemic symptoms, no causative mutation in the corresponding genes and the normal appearance of the vitreous.

Peripheral abnormality has also been seen in age-related macular degeneration (AMD) or in elderly patients [16,17,18]. We could not totally differentiate the senile reticular pigmentary changes, especially in the elderly cases, despite the fact that we excluded cases with AMD features. However, it is unlikely that such age-related changes would already occur in a patient’s 20s. The reduced amplitude of ERG indicates pan retinal dysfunction, which may not be present in senile peripheral changes. In addition, the present cases tended to show a clear border and more prominent pigmentary changes than the reported age-related changes.

Two cases had myotonic dystrophy in the cohort. It is known that myotonic dystrophy may accompany peripheral atrophic and/or pigmentary changes [19,20,21]. However, the peripheral change is less focused compared to the butterfly-shaped or reticular macular changes seen in the disease [22], The present cases can be representative examples on how the peripheral lesion appears in wide-field FAF images. Care should be taken for such unusual features, because ophthalmic findings may be the earliest symptom of inherited neurodegenerative diseases [23].

In conclusion, we reported characteristics of concentric RP in which retinal degeneration was limited to the periphery. Myotonic dystrophy-associated retinopathy as well as ADVIRC were the important differential diagnoses. We assume that many patients are undetected or left undiagnosed due to the mild symptom. Further studies are warranted for determining the prevalence, clinical course and difference of concentric RP from typical RP.

Author Contributions

Conceptualization, A.O.; methodology, M.N., A.O., S.N. and F.M.; formal analysis, A.O., S.N., Y.O., M.O. and F.M.; investigation, M.N., A.O., M.M., H.O.I., T.H., S.N. and M.O.; resources, A.O., F.M. and A.T.; writing—original draft preparation, M.N. and A.O.; writing—review and editing, M.M., H.O.I., T.H., S.N., Y.O., M.O., F.M. and A.T.; supervision, A.T.; funding acquisition, A.O. and F.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by JSPS KAKENHI (17H06820 and 19K09929, Japan Society for the Promotion of Science, Tokyo, Japan) and Japan Agency for Medical Research and Development (AMED).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of Kyoto University (protocol code R2198, 09 October, 2019 and G0746-8, 12 November 2019).

Informed Consent Statement

Informed consent was obtained from all subjects who participated in genetic testing. For reviewing clinical records other than the genetic results, patient consent was waived due to the retrospective design.

Data Availability Statement

All the relevant data are presented. Other data are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Verbakel S.K., van Huet R.A.C., Boon C.J.F., den Hollander A.I., Collin R.W.J., Klaver C.C.W., Hoyng C.B., Roepman R., Klevering B.J. Non-syndromic retinitis pigmentosa. Prog. Retin. Eye Res. 2018;66:157–186. doi: 10.1016/j.preteyeres.2018.03.005. [DOI] [PubMed] [Google Scholar]
  • 2.Quinn N., Csincsik L., Flynn E., Curcio C.A., Kiss S., Sadda S.R., Hogg R., Peto T., Lengyel I. The clinical relevance of visualising the peripheral retina. Prog. Retin. Eye Res. 2019;68:83–109. doi: 10.1016/j.preteyeres.2018.10.001. [DOI] [PubMed] [Google Scholar]
  • 3.Pichi F., Abboud E.B., Ghazi N.G., Khan A.O. Fundus autofluorescence imaging in hereditary retinal diseases. Acta Ophthalmol. 2018;96:e549–e561. doi: 10.1111/aos.13602. [DOI] [PubMed] [Google Scholar]
  • 4.Oishi A., Miyata M., Numa S., Otsuka Y., Oishi M., Tsujikawa A. Wide-field fundus autofluorescence imaging in patients with hereditary retinal degeneration: A literature review. Int. J. Retin. Vitr. 2019;5:23. doi: 10.1186/s40942-019-0173-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Grover S., Fishman G.A., Brown J., Jr. Patterns of visual field progression in patients with retinitis pigmentosa. Ophthalmology. 1998;105:1069–1075. doi: 10.1016/S0161-6420(98)96009-2. [DOI] [PubMed] [Google Scholar]
  • 6.Milam A.H., De Castro E.B., Smith J.E., Tang W.X., John S.K., Gorin M.B., Stone E.M., Aguirre G.D., Jacobson S.G. Concentric retinitis pigmentosa: Clinicopathologic correlations. Exp. Eye Res. 2001;73:493–508. doi: 10.1006/exer.2001.1059. [DOI] [PubMed] [Google Scholar]
  • 7.Kaufman S.J., Goldberg M.F., Orth D.H., Fishman G.A., Tessler H., Mizuno K. Autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol. 1982;100:272–278. doi: 10.1001/archopht.1982.01030030274008. [DOI] [PubMed] [Google Scholar]
  • 8.Yardley J., Leroy B.P., Hart-Holden N., Lafaut B.A., Loeys B., Messiaen L.M., Perveen R., Reddy M.A., Bhattacharya S.S., Traboulsi E., et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC) Investig. Ophthalmol. Vis. Sci. 2004;45:3683–3689. doi: 10.1167/iovs.04-0550. [DOI] [PubMed] [Google Scholar]
  • 9.Oishi M., Oishi A., Gotoh N., Ogino K., Higasa K., Iida K., Makiyama Y., Morooka S., Matsuda F., Yoshimura N. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and usher syndrome patients by next-generation sequencing. Investig. Ophthalmol. Vis. Sci. 2014;55:7369–7375. doi: 10.1167/iovs.14-15458. [DOI] [PubMed] [Google Scholar]
  • 10.Oishi M., Oishi A., Gotoh N., Ogino K., Higasa K., Iida K., Makiyama Y., Morooka S., Matsuda F., Yoshimura N. Next-generation sequencing-based comprehensive molecular analysis of 43 Japanese patients with cone and cone-rod dystrophies. Mol. Vis. 2016;22:150–160. [PMC free article] [PubMed] [Google Scholar]
  • 11.Numa S., Oishi A., Higasa K., Oishi M., Miyata M., Hasegawa T., Ikeda H.O., Otsuka Y., Matsuda F., Tsujikawa A. EYS is a major gene involved in retinitis pigmentosa in Japan: Genetic landscapes revealed by stepwise genetic screening. Sci. Rep. 2020;10:20770. doi: 10.1038/s41598-020-77558-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Coussa R.G., Basali D., Maeda A., DeBenedictis M., Traboulsi E.I. Sector retinitis pigmentosa: Report of ten cases and a review of the literature. Mol. Vis. 2019;25:869–889. [PMC free article] [PubMed] [Google Scholar]
  • 13.Xiao T., Xu K., Zhang X., Xie Y., Li Y. Sector retinitis pigmentosa caused by mutations of the RHO gene. Eye (Lond.) 2019;33:592–599. doi: 10.1038/s41433-018-0264-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Snead M.P., Yates J.R. Clinical and molecular genetics of Stickler syndrome. J. Med. Genet. 1999;36:353–359. [PMC free article] [PubMed] [Google Scholar]
  • 15.Meredith S.P., Richards A.J., Flanagan D.W., Scott J.D., Poulson A.V., Snead M.P. Clinical characterisation and molecular analysis of Wagner syndrome. Br. J. Ophthalmol. 2007;91:655–659. doi: 10.1136/bjo.2006.104406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Witmer M.T., Kozbial A., Daniel S., Kiss S. Peripheral autofluorescence findings in age-related macular degeneration. Acta Ophthalmol. 2012;90:e428–e433. doi: 10.1111/j.1755-3768.2012.02434.x. [DOI] [PubMed] [Google Scholar]
  • 17.Tan C.S., Heussen F., Sadda S.R. Peripheral autofluorescence and clinical findings in neovascular and non-neovascular age-related macular degeneration. Ophthalmology. 2013;120:1271–1277. doi: 10.1016/j.ophtha.2012.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Domalpally A., Clemons T.E., Danis R.P., Sadda S.R., Cukras C.A., Toth C.A., Friberg T.R., Chew E.Y. Peripheral retinal changes associated with age-related macular degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group. Ophthalmology. 2017;124:479–487. doi: 10.1016/j.ophtha.2016.12.004. [DOI] [PubMed] [Google Scholar]
  • 19.Burian H.M., Burns C.A. Ocular changes in myotonic dystrophy. Am. J. Ophthalmol. 1967;63:22–34. doi: 10.1016/0002-9394(67)90577-6. [DOI] [PubMed] [Google Scholar]
  • 20.Kimizuka Y., Kiyosawa M., Tamai M., Takase S. Retinal changes in myotonic dystrophy. Clinical and follow-up evaluation. Retina. 1993;13:129–135. doi: 10.1097/00006982-199313020-00007. [DOI] [PubMed] [Google Scholar]
  • 21.Sarks J., Penfold P., Liu H., Sarks S., Killingsworth M., Horowitz G. Retinal changes in myotonic dystrophy: A clinicomorphological study. Aust. N. Z. J. Ophthalmol. 1985;13:19–36. doi: 10.1111/j.1442-9071.1985.tb00395.x. [DOI] [PubMed] [Google Scholar]
  • 22.Abed E., D’Amico G., Rossi S., Perna A., Bianchi M.L.E., Silvestri G. Spectral domain optical coherence tomography findings in myotonic dystrophy. Neuromuscul. Disord. Nmd. 2020;30:144–150. doi: 10.1016/j.nmd.2019.11.012. [DOI] [PubMed] [Google Scholar]
  • 23.Kersten H.M., Roxburgh R.H., Danesh-Meyer H.V. Ophthalmic manifestations of inherited neurodegenerative disorders. Nat. Rev. Neurol. 2014;10:349–362. doi: 10.1038/nrneurol.2014.79. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All the relevant data are presented. Other data are available from the corresponding author on reasonable request.

Articles from Life are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES